Medical Xpress - Cardiology

NOVEMBER 21, 2024

After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to repair itself with new muscle cells becomes significantly higher, even higher than in a healthy heart. This is according to a new study from Karolinska Institutet published in the journal Circulation.

Heart Failure 104

Heart Failure Circulation 104

HCPLive

NOVEMBER 21, 2024

Ahmad Masri, MD, MS, discusses a study from AHA 2024 detailing changing risk profiles and outcomes in trials among patients with ATTR-CM.

Outcomes 125

Outcomes 125

Med Page Today

NOVEMBER 21, 2024

(MedPage Today) -- FDA advisors pushed for nuance in discussing whether andexanet alfa (Andexxa) should gain full approval, citing uncertainties about which dose and in which patients it could be best used to stop bleeding. Members of the Cellular.

122

122

Science Daily - Heart Disease

NOVEMBER 21, 2024

After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to repair itself with new muscle cells becomes significantly higher, even higher than in a healthy heart.

Heart Failure 114

Heart Failure 114

Medical Xpress - Cardiology

NOVEMBER 21, 2024

A potentially life-changing heart condition, dilated cardiomyopathy, can be caused by the cumulative influence of hundreds or thousands of genes and not just by a single "aberrant" genetic variant, as was previously thought, finds a new study led by researchers at UCL (University College London), Imperial College London and the MRC Laboratory of Medical Sciences.

Laboratory 110

Laboratory Cardiomyopathy Research 110

Science Daily - Heart Disease

NOVEMBER 21, 2024

Scientists have discovered how long-term treatment of high blood pressure with commonly prescribed drugs can destroy the kidney's ability to filter and purify blood. The finding could open the door to better ways to manage high blood pressure and other vascular diseases.

Blood Pressure 112

Blood Pressure 112

HCPLive

NOVEMBER 21, 2024

HCPLive spoke with Kastl at NASPGHAN about the team’s study on the immune response to the COVID-19 vaccination among children with IBD.

COVID-19 107

COVID-19 107

HCPLive

NOVEMBER 21, 2024

Birgit Vogel, MD discusses racial inequities and geographic variations in peripheral artery disease care in the United States.

Peripheral Arterial Disease 105

Peripheral Arterial Disease 105

Medical Xpress - Cardiology

NOVEMBER 21, 2024

A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows.

Heart Failure 98

Heart Failure Diabetes 98

Journal of Cardiothoracic Surgery

NOVEMBER 21, 2024

As the current guidelines on myocardial revascularization recommend, transit-time flow measurement (TTFM) is increasingly used for intraoperative graft flow analysis during coronary artery bypass grafting (CAB.

Coronary Artery Bypass Graft 96

Coronary Artery Bypass Graft 96

Science Daily - Heart Disease

NOVEMBER 21, 2024

A potentially life-changing heart condition, dilated cardiomyopathy, can be caused by the cumulative influence of hundreds or thousands of genes and not just by a single 'aberrant' genetic variant, as was previously thought, finds a new study.

Cardiomyopathy 91

Cardiomyopathy 91

HCPLive

NOVEMBER 21, 2024

Loomba reviews safety and efficacy data for the thyroid hormone receptor beta agonist from a phase 2a trial presented at AASLD The Liver Meeting 2024.

78

78

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

BackgroundIt's recognized that stress hyperglycemia ratio (SHR) is considered a significant indicator of poor prognosis in many diseases. However, its role in critically ill patients with acute heart failure (acute HF) remains underexplored.MethodsWe conducted a retrospective cohort study on patients with acute HF included in the Medical Information Mart for Intensive Care IV (MIMIC-IV) version 2.2 database.

Heart Failure 59

Heart Failure Research 59

Becker's Hospital Review - Cardiology

NOVEMBER 21, 2024

Arizona, Louisiana, Michigan, Ohio, Pennsylvania and Texas have the most top-ranked hospitals for heart valve replacement in the U.S., according to the WebMD Choice Awards.

Heart Valves 69

Heart Valves Hospital 69

American College of Cardiology

NOVEMBER 21, 2024

"CV Sports Chat" is an interview series including expert discussions relative to sports and exercise cardiology and the health care management of athletes.

Tachycardia 66

Tachycardia Exercise Article 66

Circulation

NOVEMBER 21, 2024

Circulation, Ahead of Print. Right ventricular outflow dysfunction, manifesting as stenosis, regurgitation, or both, is nearly universal in patients with repaired tetralogy of Fallot, precipitating a complex pathophysiological cascade that leads to increasing rates of morbidity and mortality with advancing age. As the number of adolescent and adult patients with repaired tetralogy of Fallot continues to grow as a result of excellent survival during infancy, the need to improve late outcomes has

Quality of Life 81

Quality of Life Pulmonary Stenosis Arrhythmia 81

HCPLive

NOVEMBER 21, 2024

The investigators concluded that chronic psychological stress substantially impacts skin homeostasis and, consequently, skin aging.

64

64

AMS Cardiology

NOVEMBER 21, 2024

While the holidays themselves can’t cause a heart attack , certain things people do during the hectic, festive season may stress their heart health more than they realize. Heart attacks and other cardiac events, such as heart failure flare-ups and “holiday heart syndrome” – a term used to describe palpitations induced by alcohol consumption – often surge during the winter holidays.

Heart Attack 52

Heart Attack Heart attacks Heart Failure Blood Pressure 52

HCPLive

NOVEMBER 21, 2024

Milind Desai, MD describes favorable real-world safety outcomes from mavacamten use over 22 months of the Risk Evaluation and Mitigation Strategy (REMS) program.

Outcomes 64

Outcomes 64

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

BackgroundHeart failure is a significant worldwide health problem that leads to mortality. Therefore, this study aimed to evaluate treatment outcomes and associated factors of heart failure patients who were admitted to hospitals in the southwest of Ethiopia.Methods and participantsA multicenter prospective observational study was conducted from 1 February to 1 August 2021.

Heart Failure 59

Heart Failure Hospital Risk Factors Outcomes 59

HCPLive

NOVEMBER 21, 2024

In this episode, hosts break down a pair of studies from AHA 2024, BPROAD and SUMMIT, as well as a study in JAMA projecting semaglutide eligibility in US adults.

Diabetes 64

Diabetes 64

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder. The abnormal accumulation of metabolic substrates induces inflammation and fibrosis in cells, resulting in organ dysfunction. The clinical manifestations of FD are diverse and non-specific. In the present study, we report a case initially treated as obstructive hypertrophic cardiomyopathy for several years, which was finally identified as FD through whole-exome sequencing (WES).

Cardiomyopathy 52

Cardiomyopathy Aortic valve Aortic Hospital 52

HCPLive

NOVEMBER 21, 2024

Clowse discussed findings from the phase 3 PHOENYCS GO trial presented at the 2024 ACR Convergence.

59

59

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

BackgroundRupture of an abdominal aortic aneurysm (AAA) is a life-threatening emergency, with untreated cases nearing a 100% mortality rate. This case presents a rare complication of AAA rupture with an infected retroperitoneal hematoma, emphasizing the importance of timely diagnosis and a multidisciplinary approach.Case presentationA 59-year-old male presented with lower back pain, fever, and difficulty moving, persisting for three weeks.

Aneurysm 59

Aneurysm Aortic Outcomes 59

American College of Cardiology

NOVEMBER 21, 2024

In this special edition of Eagle’s Eye View, Dr. Eagle looks at the most important trials presented at the recent AHA scientific sessions.

Article 56

Article 56

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

ObjectiveThis study aims to explore the effect of a case management model that breaks through the temporal and spatial characteristics on the at-home phase II exercise rehabilitation of postoperative patients treated with percutaneous coronary intervention (PCI).MethodsWe used the convenience sampling method to select 103 patients with coronary artery disease (53 in the observation group and 50 in the control group) who were admitted to the Department of Cardiovascular Internal Medicine at the J

Exercise 59

Exercise Coronary Artery Disease Cholesterol BMI 59

Open Heart

NOVEMBER 21, 2024

Background Ventricular arrhythmias (VAs) frequently occur in the acute phase of myocarditis. Possible arrhythmic recurrences and the risk of sudden cardiac death (SCD) in this setting are reasons for concern, and limited data have been published to guide clinical management of these patients. The aim of the present paper is to report the incidence of major arrhythmic events, defined as sustained VA, SCD and appropriate implantable cardiac-defibrillator (ICD) treatment, in patients with acute myo

Sudden Cardiac Death 52

Sudden Cardiac Death Defibrillator Risk Factors Tachycardia 52

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

BackgroundFollowing the identification of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, research in this area has experienced significant growth. However, a thorough bibliometric analysis of this burgeoning field remains conspicuously absent. The current study aims to delineate research hotspots and anticipate future trends on PCSK9 inhibitors employing bibliometric analysis.MethodsA systematic search was conducted in the Web of Science Core Collection (WoSCC) to identify sch

Peripheral Arterial Disease 52

Peripheral Arterial Disease Research Document Article 52

Open Heart

NOVEMBER 21, 2024

Introduction Percutaneous coronary intervention (PCI) is performed by interventional cardiologists who, over their career, are exposed to substantial X-ray radiation and also face potential musculoskeletal injuries from the prolonged wearing of heavy protective equipment. Patients are also at risk from radiation exposure. Robotic-assisted PCI (R-PCI) allows millimetre control of the coronary guide-catheter, guidewires and intracoronary devices via three joysticks and touchscreens located within

Technology 52

Technology Anatomy Outcomes Hospital 52

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Background and aimEstimated glomerular filtration rate (eGFR) is a key indicator of kidney function and is associated with numerous health conditions. This study examines the association between eGFR and cardiovascular disease (CVD) risk in a representative cohort of the US adult population.MethodsA cross-sectional analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018.

Cardiovascular Disease 52

Cardiovascular Disease Myocardial Infarction Kidney Disease Angina 52

HCPLive

NOVEMBER 21, 2024

Birgit Vogel, MD discusses racial inequities and geographic variations in peripheral artery disease care in the United States.

Peripheral Arterial Disease 52

Peripheral Arterial Disease 52

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

IntroductionIn atrial fibrillation (AF) ablation, fluoroscopy has been a standard tool for catheter guidance. However, the combination of electroanatomic mapping systems (EAMs) and intracardiac echocardiography (ICE) now allows for minimal or zero-fluoroscopy procedures. Concurrently, high-power short-duration (HPSD) ablation has emerged as a promising technique, offering enhanced resistive heating while reducing conductive heating.

Atrial Fibrillation 59

Atrial Fibrillation Ablation Pulmonary Outcomes 59

HCPLive

NOVEMBER 21, 2024

Infusion reaction rates and serum level lowering were similar between 120-minute and 60-minute infusion cohorts in the phase 4 AGILE study.

52

52

Becker's Hospital Review - Cardiology

NOVEMBER 21, 2024

Baylor College of Medicine and the Texas Heart Institute, both based in Houston, will partner to establish a cardiovascular health and research center at Baylor St. Luke's Medical Center.

Research 52

Research 52

HCPLive

NOVEMBER 21, 2024

Lawitz explains issues with traditional FXR agonists for MASH treatment and how FXR314 differs, potentially offering a more safe and efficacious option.

52

52

DAIC

NOVEMBER 21, 2024

tim.hodson Thu, 11/21/2024 - 13:27 Nov. 21, 2024 — Royal Philips plans to unveil its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024 in Chicago, Dec. 1-4. The latest generation scanner features a 70 cm wide-bore design and integrates AI-enabled MR Smart Workflow solutions, designed to enhance access and diagnostic confidence to improve outcomes for more patients.

Technology 52

Technology Anatomy Biomarkers Outcomes 52

HCPLive

NOVEMBER 21, 2024

Ahmad Masri, MD, MS, discusses data from the FOREST-HCM trial examining effects of aficamten in patients with oHCM eligible for septal reduction therapy at baseline.

52

52